Tsikloferon tab n / an kish.rastv. 150mg 50 pieces

Description

Composition
Active substance:
1 tablet contains: meglumine akridonatsetat based on akridonuksusnuyu acid – 150 mg ;.
Excipients:
Povidone – 7.93 mg Calcium stearate – 3.07 mg hypromellose – 2.73 mg, polysorbate 80 – 0.27 mg of methacrylic acid ethyl acrylate copolymer – 23.21 mg Propylene Glycol – 1.79 mg.
Description:
Biconvex yellow tablets, enteric coated.
Product form:
The tablets, enteric-coated tablets, 150 mg. At 10 or 20 tablets in blisters. 1 blisters with 20 tablets 1 or 5 contour cell packs of 10 tablets together with instructions for use in a stack of cardboard.
Contraindications
Pregnancy, lactation, children under 4 years of age (due to imperfect act of swallowing) idiosyncrasy formulation components, decompensated cirrhosis.
Carefully
When digestive diseases in the acute stage (erosion, gastric ulcer and / or duodenal ulcers, gastritis and duodenitis) and allergic reactions in history before taking the drug should consult with your doctor.
Dosage
150 mg
Indications
In adults, in the treatment of: influenza and acute respiratory infections; herpes infection.
Children from the age of four in the complex therapy: of influenza and acute respiratory infections;
Herpes infection.
Children ranging from four years for the prevention of influenza and acute respiratory diseases.
Interaction with other drugs
Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic medicines and others.). It enhances the action of interferons and nucleoside analogues. It reduces the side effects of chemotherapy, interferon.
Overdose
Data on overdose of the drug available.
pharmachologic effect
Pharmacological group:
Immunostimulatory agent.
Pharmacodynamics:
Cycloferon is a low molecular interferon inducer, which defines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory and others.).
Tsikloferon effective against herpes viruses, influenza and other pathogens of acute respiratory diseases. It has a direct antiviral effect by inhibiting reproduction of the virus in the early stages (1-5e night) infection, reducing the infectivity of viral progeny, resulting in formation of defective viral particles. Increases nonspecific resistance against viral and bacterial infections.
Pharmacokinetics:
When receiving a daily dose maximum plasma concentration is reached after 2-3 hours, gradually decreases to the 8 th hour and after 24 hours TSikloferon detected in trace amounts. The half-life of 4-5 hours, so the use TSikloferon formulation at the recommended doses does not create conditions for accumulation in the body.
Pregnancy and breast-feeding
Contraindicated for use during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
Allergic reactions.
special instructions
TSikloferon not affect the ability to drive.
In diseases of the thyroid gland should consult vracha endocrinologist.
If reception of the next dose is missed, it should be as soon as possible without regard to the time interval and the doubling of the dosage rate started to continue the circuit.
In the absence of a therapeutic effect is necessary to consult a doctor.
Storage conditions
In a dry place, protected from light at a temperature not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Inside, once a day, 30 minutes before a meal, without chewing, with 1/2 cup of water, in the age dosages: Children 4-6 years: 150 mg (1 tablet) for reception; children 7-11 years: 300-450 mg (2-3 tablets) per reception; adults and children over 12 years: 450-600 (3-4 tablets) at the reception.
Repeated course it is advisable to spend 2-3 weeks after the first course.
In adults: 1. In the treatment of influenza and acute respiratory diseases, drug taking by 1, 2, 4, 6, 8 th day (treatment – 20 tablets). Treatment should begin at the first sign of the disease.
In severe flu in the first day of taking six tablets.
If necessary, additional symptomatic therapy (antipyretics, analgesics, expectorants).
2. When herpes infection take medication at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 and day (treatment of 40 tablets). Treatment is most effective when the first symptoms.
Children from the age of four:
1. When influenza and acute respiratory diseases take medication doses in the age of 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 hours. The course of treatment is from 5 to 10 techniques depending on the severity of the condition and the severity of the clinical symptoms.
2. When herpes infection take medication at 1, 2, 4, 6, 8, 11, 14-th day of treatment. The course of treatment may vary depending on the severity of the condition and severity of clinical symptoms.
3. For emergency nonspecific prevention of influenza and acute respiratory diseases (for direct contact with patients with influenza or other etiology ORZ, during an epidemic influenza): 1, 2, 4, 6, 8 th day. Further break performed 72 hours (three days) and continue the course of 11, 14, 17, 20, 23 rd day. The total rate is from 5 to 10 receptions.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist